| CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY |
26.
CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY
The
Company performed a test on the restricted net assets of consolidated subsidiaries in accordance with Securities and Exchange Commission
Regulation S-X Rule 4-08 (e) (3), “General Notes to Financial Statements” and concluded that it was applicable for the Company
to disclose the financial statements for the parent company.
The
subsidiaries did not pay any dividends to the Company for the periods presented. For the purpose of presenting parent company only financial
information, the Company records its investments in its subsidiaries under the equity method of accounting. Such investments are presented
on the separate condensed balance sheets of the Company as “Investments deficit in subsidiaries” and the loss of the subsidiaries
is presented as “Share of losses of subsidiaries”. Certain information and footnote disclosures generally included in financial
statements prepared in accordance with US GAAP have been condensed and omitted. The footnote disclosures contain supplemental information
relating to the operations of the Company, as such, these statements should be read in conjunction with the notes to the consolidated
financial statements of the Company.
The
parent company did not have significant capital and other commitments, long-term obligations, other long-term debt, or guarantees as
of December 31, 2024 and 2025.
UXIN
LIMITED
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All
amounts in thousands, except for share and per share data, unless otherwise noted)
26.
CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY (CONTINUED)
Balance
sheets
SCHEDULE OF BALANCE SHEETS
| | |
| | | |
| | |
| | |
| December
31, 2024 | | |
| December
31, 2025 | |
| | |
| RMB | | |
| RMB | |
| | |
| | | |
| | |
| ASSETS | |
| | | |
| | |
| | |
| | | |
| | |
| Cash and cash
equivalents | |
| 850 | | |
| 4,843 | |
| Amounts due from intra-Group
entities | |
| 10,144,302 | | |
| 7,358,481 | |
| Other receivables | |
| 2,457 | | |
| 1,308 | |
| Prepaid
expenses | |
| 89 | | |
| 236 | |
| | |
| | | |
| | |
| Total
assets | |
| 10,147,698 | | |
| 7,364,868 | |
| | |
| | | |
| | |
| LIABILITIES AND SHAREHOLDERS’
DEFICIT | |
| | | |
| | |
| | |
| | | |
| | |
| Liabilities | |
| | | |
| | |
| | |
| | | |
| | |
| Other payables and other
current liabilities | |
| 29,942 | | |
| 20,233 | |
| Short-term borrowings | |
| - | | |
| 39,072 | |
| Investment deficit in subsidiaries | |
| 10,391,493 | | |
| 7,448,541 | |
| Amounts
due to intra-Group entities | |
| 94,265 | | |
| 87,910 | |
| | |
| | | |
| | |
| Total
liabilities | |
| 10,515,700 | | |
| 7,595,756 | |
| | |
| | | |
| | |
| Shareholders’ deficit | |
| | | |
| | |
| | |
| | | |
| | |
| Ordinary shares (US$0.0001
par value, 190,100,000,000 and 190,100,000,000 shares authorized as of December 31, 2024 and 2025, respectively; 56,354,853,138 Class
A ordinary shares and 40,809,861 Class B ordinary shares issued and outstanding as of December 31, 2024; 64,892,337,575 Class A ordinary
shares and 40,809,861 Class B ordinary shares issued and outstanding as of December 31, 2025) | |
| 39,816 | | |
| 45,922 | |
| Additional paid-in capital | |
| 19,007,948 | | |
| 19,370,282 | |
| Subscription receivable
from shareholders | |
| (60,467 | ) | |
| (21,165 | ) |
| Accumulated other comprehensive
income | |
| 227,718 | | |
| 234,630 | |
| Accumulated
deficit | |
| (19,583,017 | ) | |
| (19,860,557 | ) |
| Total shareholders’
deficit | |
| (368,002 | ) | |
| (230,888 | ) |
| | |
| | | |
| | |
| Total
liabilities and shareholders’ deficit | |
| 10,147,698 | | |
| 7,364,868 | |
UXIN
LIMITED
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All
amounts in thousands, except for share and per share data, unless otherwise noted)
26.
CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY (CONTINUED)
Statements
of comprehensive loss
SCHEDULE OF STATEMENT OF COMPREHENSIVE LOSS
| | |
For
the fiscal
year
ended
March
31, | | |
For
the nine
months
ended
December
31, | | |
For
the year
ended
December
31, | |
| | |
2024 | | |
2024 | | |
2025 | |
| | |
RMB | | |
RMB | | |
RMB | |
| | |
| | | |
| | | |
| | |
| Operation expense | |
| | | |
| | | |
| | |
| General and
administrative | |
| (73,236 | ) | |
| (89,099 | ) | |
| (37,587 | ) |
| Total
operating expenses | |
| (73,236 | ) | |
| (89,099 | ) | |
| (37,587 | ) |
| | |
| | | |
| | | |
| | |
| Loss from operations | |
| (73,236 | ) | |
| (89,099 | ) | |
| (37,587 | ) |
| | |
| | | |
| | | |
| | |
| Share of losses of subsidiaries | |
| (299,613 | ) | |
| (114,011 | ) | |
| (237,157 | ) |
| Interest expense, net | |
| (546 | ) | |
| (1,806 | ) | |
| (3,459 | ) |
| Other income, net | |
| 12,746 | | |
| 604 | | |
| 1,859 | |
| Foreign exchange gain/(loss) | |
| 38 | | |
| - | | |
| (1,196 | ) |
| Fair value impact of the
issuance of senior convertible preferred shares | |
| (11,776 | ) | |
| - | | |
| - | |
| Net
loss | |
| (372,387 | ) | |
| (204,312 | ) | |
| (277,540 | ) |
| | |
| | | |
| | | |
| | |
| Deemed dividend to preferred
shareholders due to triggering of a down round feature | |
| (2,060,254 | ) | |
| - | | |
| - | |
| Net loss attributable to
ordinary shareholders | |
| (2,432,641 | ) | |
| (204,312 | ) | |
| (277,540 | ) |
| | |
| | | |
| | | |
| | |
| Net loss | |
| (372,387 | ) | |
| (204,312 | ) | |
| (277,540 | ) |
| Other comprehensive income | |
| | | |
| | | |
| | |
| Foreign currency translation | |
| 4,905 | | |
| 2,628 | | |
| 6,912 | |
| Total
comprehensive loss | |
| (367,482 | ) | |
| (201,684 | ) | |
| (270,628 | ) |
Statements
of cash flow
SCHEDULE OF STATEMENTS OF CASH FLOWS
| | |
For
the fiscal
year
ended
March
31, | | |
For
the nine
months
ended
December
31, | | |
For
the year
ended
December
31, | |
| | |
2024 | | |
2024 | | |
2025 | |
| | |
RMB | | |
RMB | | |
RMB | |
| | |
| | | |
| | | |
| | |
| Net cash used
in operating activities | |
| (11,150 | ) | |
| (3,719 | ) | |
| (12,322 | ) |
| Net cash used in investing
activities | |
| (204,327 | ) | |
| (69,612 | ) | |
| (344,518 | ) |
| Net cash generated from
financing activities | |
| 153,269 | | |
| 71,953 | | |
| 360,845 | |
| Effect of exchange rate
changes on cash and cash equivalents | |
| 2,170 | | |
| 22 | | |
| (12 | ) |
| Net (decrease)/increase in cash and cash equivalents | |
| (60,038 | ) | |
| (1,356 | ) | |
| 3,993 | |
| Cash and cash equivalents
at beginning of the period | |
| 62,244 | | |
| 2,206 | | |
| 850 | |
| Cash and cash equivalents
at end of the period | |
| 2,206 | | |
| 850 | | |
| 4,843 | |
|